They have fueled clinical trials of subcutaneous and oral immunotherapy and led to the introduction of new treatment modalities, such as monoclonal anti-IgE therapy and biologics for treatments of asthma and atopic dermatitis, and early introduction of foods for prevention of food allergy (5, 6). The gene discussed is IGHE; the disease is food allergy.